Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 7
Submit an article Journal homepage
107
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Michael Miller University of Maryland Medical Center, Baltimore, MD, USA
,
Adrian Dobs Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
Zhong Yuan Merck & Co., Inc., West Point, PA, USA
,
Wendy P. Battisti Merck & Co., Inc., West Point, PA, USA
,
Hannah Borisute Merck & Co., Inc., West Point, PA, USA
&
Joanne Palmisano Merck & Co., Inc., West Point, PA, USACorrespondence[email protected]
Pages 1087-1094 | Accepted 29 Apr 2004, Published online: 01 Jun 2004

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

M. Miller, A. Dobs, Z. Yuan, W. P. Battisti & J. Palmisano. (2006) The effect of simvastatin on triglyceride-rich lipoproteins in patients with type 2 diabetic dyslipidemia: a SILHOUETTE Trial Sub-study . Current Medical Research and Opinion 22:2, pages 343-350.
Read now

Articles from other publishers (10)

Alexander Hodkinson, Dialechti Tsimpida, Evangelos Kontopantelis, Martin K Rutter, Mamas A Mamas & Maria Panagioti. (2022) Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. BMJ, pages e067731.
Crossref
Guyi Wang, Jiayi Deng, Jinxiu Li, Chenfang Wu, Haiyun Dong, Shangjie Wu & Yanjun Zhong. (2021) The Role of High-Density Lipoprotein in COVID-19. Frontiers in Pharmacology 12.
Crossref
Philipp Mourikis, Saif Zako, Lisa Dannenberg, Amir M. Nia, Yvonne Heinen, Lucas Busch, Hannah Richter, Thomas Hohlfeld, Tobias Zeus, Malte Kelm & Amin Polzin. (2020) Lipid lowering therapy in cardiovascular disease: From myth to molecular reality. Pharmacology & Therapeutics 213, pages 107592.
Crossref
Alireza Milajerdi, Alireza Sadeghi, Seyed Mohammad Mousavi, Bagher Larijani & Ahmad Esmaillzadeh. (2020) Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-analysis of Data From Randomized Controlled Trials. Clinical Therapeutics 42:2, pages e13-e31.
Crossref
Sonja V. Sorensen, Kevin D. Frick, Alexander Wade, Robert Simko & Russel Burge. (2009) Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia. Clinical Therapeutics 31:4, pages 862-879.
Crossref
Fergus McTaggart & Peter Jones. (2008) Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit. Cardiovascular Drugs and Therapy 22:4, pages 321-338.
Crossref
Adrian Dobs, Michael Miller, Paul T. DeLucca, Karen E. Ramsey, Andrew M. Tershakovec & Wendy Horn. (2008) Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia. Journal of Clinical Lipidology 2:1, pages 12-18.
Crossref
Rodrigo O. Moreira, Raul D. Santos, Lilton Martinez, Fabiana C. Saldanha, Jara Lucia A.C. Pimenta, Josefina Feijoo, Natalie Jahnke, Otávio C. Mangile & Rosane Kupfer. (2006) Perfil lipídico de pacientes com alto risco para eventos cardiovasculares na prática clínica diária. Arquivos Brasileiros de Endocrinologia & Metabologia 50:3, pages 481-489.
Crossref
Maurizio Bevilacqua, Velella Righini, Massimo Barrella, Tarcisio Vago, Enrica Chebat & Ligia J. Dominguez. (2005) Effects of fluvastatin slow-release (xl 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes. Advances in Therapy 22:6, pages 527-542.
Crossref
L. M. Gaudiani, A. Lewin, L. Meneghini, I. Perevozskaya, D. Plotkin, Y. Mitchel & S. Shah. (2005) Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients. Diabetes, Obesity and Metabolism 7:1, pages 88-97.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.